Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Tapeworm Infestation

  • Author: Lisandro Irizarry, MD, MPH, FACEP; Chief Editor: Jeter (Jay) Pritchard Taylor, III, MD  more...
 
Updated: Jul 28, 2015
 

Background

Tapeworms are long, segmented worms of the class Cestoda, which comprise 1 of 3 classes of parasitic worms (worms that require a host within which to mature). The other classes are Nematoda and Trematoda. These worms lack an intestinal tract and instead can absorb nutrients through their integument.

The adult consists of a head (scolex), where the worms attach to the mucosa of the intestine; a neck; and a segmented body that contains both male gonads and female gonads (proglottids).

See the image below.

Adult tapeworm of Dipylidium caninum. Image courte Adult tapeworm of Dipylidium caninum. Image courtesy of the Centers for Disease Control and Prevention (CDC).

Cestodes include the following:

  • Taenia solium
  • Taenia saginata
  • Taenia asiatica [1]
  • Diphyllobothrium
  • Hymenolepis
  • Dipylidium caninum
  • Echinococcus
  • Spirometra
  • Taenia multiceps
Next

Pathophysiology

Typically, a cestode requires one or more intermediate hosts in their life cycle. The life cycle is as follows:

  • The eggs are passed into the environment from the primary host.
  • The eggs are ingested by an intermediate host in which they hatch.
  • The larvae enter the tissues of the intermediate host and encyst.
  • The primary host ingests the cysts in the flesh of the intermediate host.

When humans are the primary hosts, the adult cestode is limited to the intestinal tract. When humans are the intermediate hosts, the larvae are within the tissues, migrating through the different organ systems.

In most cestode infestations (ie, T solium, T saginata, Diphyllobothrium species, Hymenolepis species, and D caninum), humans are the primary hosts. Adult worms survive inside their human hosts, where they are limited to the intestinal tract. Human fecal contamination of the environment is needed to sustain these life cycles.

In the remaining cestodes (ie, Echinococcus species, Spirometra species, and T multiceps), humans function as the intermediate hosts. Larvae exist within the tissues and migrate through different organ systems.

Hymenolepis species and T solium are the only cestodes for which humans can function as both primary hosts and intermediate hosts. Hymenolepis diminuta is primarily a cestode of rodents, although humans can be a rare and accidental hosts in the life cycle. Humans are infected by swallowing insects that contain cysticercoid larvae, most often by ingesting mealworms or grain beetles that infest dried grains, cereals, flour, and dried fruit.

Table 1. Cestodes and Their Hosts (Open Table in a new window)

Cestode Primary Host Intermediate Host
T solium Humans Pigs, humans, dogs, cats, sheep
T saginata Humans Cattle
Diphyllobothrium Humans Fish
Hymenolepis Humans Hymenolepis nana: None; Hymenolepis diminuta: Rodents
D caninum Humans, dogs, cats Fleas on dogs/cats
Echinococcus Dogs Humans, sheep, cattle, goats, horses, camel
Spirometra Humans  
T multiceps   Hares, rabbits, squirrels, humans (rarely)

 

Diagram of the Echinococcus life cycle. Image cour Diagram of the Echinococcus life cycle. Image courtesy of the Centers for Disease Control and Prevention.
Previous
Next

Epidemiology

Frequency

United States

Although many cestode infestations occur worldwide, only a few are common in the United States.

Diphyllobothriasis is an infection that occurs from eating raw or undercooked fish infected with Diphyllobothrium species. Diphyllobothrium organisms are present in lakes, rivers, and deltas of freshwaters. Eskimos in western Alaska and the West Coast of the United States are frequent hosts.

Echinococcus multilocularis causes alveolar echinococcosis, which occurs only in the northern hemisphere. In the United States, it occurs particularly in Alaska. Echinococcus granulosis causes hydatid disease, which occurs worldwide.

Although infection with T saginata (obtained from raw or undercooked beef) occurs worldwide, the prevalence in the United States is less than 1% because most cattle in the United States are free of the parasite. Infection with T solium is rare, but with the growing number of immigrants from endemic areas, the frequency is changing.

Infection with H nana is the most frequently diagnosed cestode infection in the United States.

Spirometra species cause sparganosis, which occurs accidentally in humans who ingest water containing infected cyclops, eating raw or inadequately cooked flesh of snakes, frogs, or birds. It has been reported mainly in the southeastern region of the United States.

International

T saginata has a high endemicity in Latin America, Africa, Middle East, and central Asia and has a moderate endemicity in Europe, south Asia, Japan, and the Philippines.

T solium is prevalent in Latin America, the Slavic countries, Africa, southeast Asia, India, and China. The prevalence of T solium infection is low in northwestern Europe and is rare or absent in Canada. Cysticercosis, caused by infection with the larvae stage of the tapeworm, is endemic in all Latin American countries (except Chile, Argentina, and Uruguay).

Diphyllobothrium infection is prevalent in northern Europe (Finland, east Prussia, Russian Karelia), Canada, Africa, Japan, Taiwan, Manchuria, Siberia, Papua New Guinea, Australia, and South America.

H nana infection is the most common cestode of humans. It is prevalent in areas of poor hygiene and sanitation, especially in the warm and arid countries of the Mediterranean, Indian subcontinent, and South America. The prevalence in children in these areas may reach 20%. Infection rates are highest among children.

E multilocularis infection occurs only in the northern hemisphere, especially in central Europe, Russia, China, Japan, Canada, and north Africa. Few regions in the world are completely free from E granulosis.Echinococcus vogeli and Echinococcus oligarthrus infections occur in Central America and South America.

Infection with Spirometra species has been reported worldwide but especially in east Asia (China, Japan, and Korea) and southeast Asia (Malaysia, India, and the Philippines).

Mortality/Morbidity

Many cestode infestations are asymptomatic. However, once symptoms occur, they are usually vague GI complaints such as abdominal pain, anorexia, weight loss, or malaise.

Some of the more serious infestations result in symptoms from mass effects on vital organs, inflammatory responses, nutritional deficiencies, and the potential of fatal anaphylaxis.

Cysticercosis is a clinical syndrome of expanding embryonal cysts that occurs with T solium. The cysticerci that develop with T solium infestations can be found anywhere in the body, but they mainly occur in the central nervous system (neurocysticercosis) and skeletal muscles, causing local inflammatory responses and mass effects from the cystic growth. Cysticercosis is a common parasitic disease of the CNS. One of the most common manifestations is seizure.[2, 3] In endemic areas, it is a major cause of epilepsy. Neurocysticercosis may be the cause of death in many of these affected areas and may leave infected persons with irreversible brain damage.

The first study to systematically collect data on the frequency of neurocysticercosis worldwide found that one third of patients with epilepsy living in endemic communities showed neurocysticercosis brain lesions.[4]

Diphyllobothrium species absorb a large amount of vitamin B-12 and interfere with vitamin B-12 absorption from the ileum, resulting in vitamin B-12 deficiency (this can also occur with Taenia species). Severity depends on the proximity of the worm to the ileum, where vitamin B-12 is mainly absorbed in humans. Clinically, it resembles pernicious anemia (ie, hyperchromic, macrocytic, megaloblastic anemia) that responds well to vitamin supplementation therapy without long-term sequelae.

In Echinococcus infestations, humans ingest the eggs and the embryos escape, penetrate intestinal mucosa, and enter the portal circulation to invade other organs, mainly the liver (60%) and lungs (25%). The patient remains asymptomatic until the cysts cause a mass effect on the organ, which can be 5-20 years after the initial infestation.

Rupture or leakage of an Echinococcus cyst produces symptoms of fever, pruritus, urticaria, eosinophilia, and potentially fatal anaphylaxis.

Pulmonary hydatid cysts may rupture into the bronchial tree produce cough, dyspnea, chest pain, or hemoptysis. Pulmonary cysts rupture into the pleural space can result in abscess formation and pneumothorax, with or without pleural effusion. In addition, fever and acute hypersensitivity reactions ranging from wheezing to anaphylaxis can occur following cyst rupture.

If alveolar hydatid disease is left untreated, more than 90% of patients will die within 10 years from the onset of symptoms and almost 100% by 15 years.

Race

No racial risks or protections regarding cestode infestations are known.

Sex

Gender differences neither protect nor increase the risk of cestode infections.

Age

Many cestode infections are common in children as a result of their youthful habits and relatively less adequate hygiene. For instance, D caninum, one of the most common parasites of domestic dogs and cats, is typically obtained from fleas that live in the fur of these animals. Although infection of D caninum is rare, children, especially those who enjoy handling animals, are affected more frequently than adults.

Previous
 
 
Contributor Information and Disclosures
Author

Lisandro Irizarry, MD, MPH, FACEP Chair, Department of Emergency Medicine, Wyckoff Heights Medical Center

Lisandro Irizarry, MD, MPH, FACEP is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Medical Toxicology, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Kim A Guishard, MD Vice Chairman, Department of Emergency Medicine, Wycroft Heights Medical Center

Kim A Guishard, MD is a member of the following medical societies: American College of Emergency Physicians, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Eddy S Lang, MDCM, CCFP(EM), CSPQ Associate Professor, Senior Researcher, Division of Emergency Medicine, Department of Family Medicine, University of Calgary Faculty of Medicine; Assistant Professor, Department of Family Medicine, McGill University Faculty of Medicine, Canada

Eddy S Lang, MDCM, CCFP(EM), CSPQ is a member of the following medical societies: American College of Emergency Physicians, Society for Academic Emergency Medicine, Canadian Association of Emergency Physicians

Disclosure: Nothing to disclose.

Chief Editor

Jeter (Jay) Pritchard Taylor, III, MD Assistant Professor, Department of Surgery, University of South Carolina School of Medicine; Attending Physician, Clinical Instructor, Compliance Officer, Department of Emergency Medicine, Palmetto Richland Hospital

Jeter (Jay) Pritchard Taylor, III, MD is a member of the following medical societies: American Academy of Emergency Medicine, South Carolina Medical Association, Columbia Medical Society, South Carolina College of Emergency Physicians, American College of Emergency Physicians, American Medical Association, Society for Academic Emergency Medicine

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Chief Editor for Medscape.

Additional Contributors

Richard S Krause, MD Senior Clinical Faculty/Clinical Assistant Professor, Department of Emergency Medicine, University of Buffalo State University of New York School of Medicine and Biomedical Sciences

Richard S Krause, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author, Raquel Mora, MD, to the development and writing of this article.

References
  1. Eom KS, Rim HJ. Morphologic descriptions of Taenia asiatica sp. n. Korean J Parasitol. March 1993. 31:1-6. [Medline].

  2. Del Brutto OH. Neurocysticercosis. Semin Neurol. 2005 Sep. 25(3):243-51. [Medline].

  3. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. 1992 Feb. 42(2):389-92. [Medline].

  4. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010 Nov 2. 4(11):e870. [Medline]. [Full Text].

  5. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001 Jul 24. 57(2):177-83. [Medline].

  6. Stefanic S, Shaikenov BS, Deplazes P, Dinkel A, Torgerson PR, Mathis A. Polymerase chain reaction for detection of patent infections of Echinococcus granulosus ("sheep strain") in naturally infected dogs. Parasitol Res. 2004 Mar. 92(4):347-51. [Medline].

  7. Craig P, Ito A. Intestinal cestodes. Curr Opin Infect Dis. 2007 Oct. 20(5):524-32. [Medline].

  8. Garcia HH, Del Brutto OH, Nash TE, White AC Jr, Tsang VC, Gilman RH. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg. 2005 Jan. 72(1):3-9. [Medline].

  9. Garcia HH, Gonzalez AE, Gilman RH. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis. 2003 Oct. 16(5):411-9. [Medline].

  10. Kumar H, Jain K, Jain R. A study of prevalence of intestinal worm infestation and efficacy of anthelminthic drugs. Med J Armed Forces India. 2014 Apr. 70(2):144-8. [Medline]. [Full Text].

  11. Matthaiou DK, Panos G, Adamidi ES, Falagas ME. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl Trop Dis. 2008 Mar 12. 2(3):e194. [Medline]. [Full Text].

  12. Otte WM, Singla M, Sander JW, Singh G. Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. Neurology. 2013 Jan 8. 80(2):152-62. [Medline]. [Full Text].

  13. Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev. 2010 Mar 17. CD000215. [Medline].

  14. Sinha S, Sharma BS. Intraventricular neurocysticercosis: a review of current status and management issues. Br J Neurosurg. 2012 Jun. 26(3):305-9. [Medline].

  15. Khade P, Lemos RS, Toussaint LG. What is the Utility of Postoperative Antihelminthic Therapy after Resection for Intraventricular Neurocysticercosis?. World Neurosurg. 2011 Nov 7. [Medline].

  16. Morar R, Feldman C. Pulmonary echinococcosis. Eur Respir J. 2003 Jun. 21(6):1069-77. [Medline].

  17. Chen W, Xusheng L. Laparoscopic surgical techniques in patients with hepatic hydatid cyst. Am J Surg. 2007 Aug. 194(2):243-7. [Medline].

  18. Ozturk G, Aydinli B, Yildirgan MI, Basoglu M, Atamanalp SS, Polat KY. Posttraumatic free intraperitoneal rupture of liver cystic echinococcosis: a case series and review of literature. Am J Surg. 2007 Sep. 194(3):313-6. [Medline].

  19. Barnett K, Emder P, Day AS, Selby WS. Tapeworm infestation: a cause of iron deficiency anemia shown by capsule endoscopy. Gastrointest Endosc. 2007 Sep. 66(3):625-7. [Medline].

  20. Bildik N, Cevik A, Altintas M, Ekinci H, Canberk M, Gulmen M. Efficacy of preoperative albendazole use according to months in hydatid cyst of the liver. J Clin Gastroenterol. 2007 Mar. 41(3):312-6. [Medline].

  21. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis. 2002 Dec. 2(12):751-62. [Medline].

  22. Chrieki M. Echinococcosis--an emerging parasite in the immigrant population. Am Fam Physician. 2002 Sep 1. 66(5):817-20. [Medline].

  23. Christie JD, Garcia LS. Emerging parasitic infections. Clin Lab Med. Dec 2002. 24(3):737-72.

  24. Cox FE. History of human parasitic diseases. Infect Dis Clin North Am. 2004 Jun. 18(2):171-88, table of contents. [Medline].

  25. Craig P. Echinococcus multilocularis. Curr Opin Infect Dis. 2003 Oct. 16(5):437-44. [Medline].

  26. Craig PS, McManus DP, Lightowlers MW, Chabalgoity JA, Garcia HH, Gavidia CM. Prevention and control of cystic echinococcosis. Lancet Infect Dis. 2007 Jun. 7(6):385-94. [Medline].

  27. Falagas ME, Bliziotis IA. Albendazole for the treatment of human echinococcosis: a review of comparative clinical trials. Am J Med Sci. 2007 Sep. 334(3):171-9. [Medline].

  28. Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005 Oct. 4(10):653-61. [Medline].

  29. Garcia HH, Gonzalez AE, Gilman RH. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis. 2003 Oct. 16(5):411-9. [Medline].

  30. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004 Jan 15. 350(3):249-58. [Medline].

  31. Khuroo MS, Wani NA, Javid G, Khan BA, Yattoo GN, Shah AH, et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med. 1997 Sep 25. 337(13):881-7. [Medline].

  32. Kolars JC, Fischer PR. Evaluation of diarrhea in the returned traveler. Prim Care. 2002 Dec. 29(4):931-45. [Medline].

  33. Kraft R. Cysticercosis: an emerging parasitic disease. Am Fam Physician. 2007 Jul 1. 76(1):91-6. [Medline].

  34. Loukas A, Hotez PJ. Chemotherapy of helminth infections. Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's Pharmacology. 11th ed. McGraw-Hill; 2006. 1121-1141.

  35. McAdam AJ, Sharpe AH. Infectious diseases. Kumar V, Abbas AK, Fausto N, eds. Kumar, Robbins, and Cotran: Pathologic Basis of Disease. 7th ed. Philadelphia: Saunders; 2005. 838-8.

  36. Moon TD, Oberhelman RA. Antiparasitic therapy in children. Pediatr Clin North Am. 2005 Jun. 52(3):917-48, viii. [Medline].

  37. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proaño JV. Treatment of neurocysticercosis: current status and future research needs. Neurology. 2006 Oct 10. 67(7):1120-7. [Medline].

  38. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis. 2002 Jun. 8(6):608-13. [Medline].

  39. Romig T. Epidemiology of echinococcosis. Langenbecks Arch Surg. 2003 Sep. 388(4):209-17. [Medline].

  40. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. 2004 Nov 9. 63(9):1559-64. [Medline].

  41. White AC, Weller PF. Cestodes. Kasper DL, Braunwald E, Fauci AS, eds. Harrison's Principles of Internal Medicine. 16th ed. McGraw-Hill; 2005. 1272-7.

  42. Drugs for Parasitic Infections. 3rd ed. New Rochelle, NY: The Medical Letter; 2013.

 
Previous
Next
 
Adult tapeworm of Dipylidium caninum. Image courtesy of the Centers for Disease Control and Prevention (CDC).
Ultrasonographic appearance of echinococcal cysts (Gharbi type I, World Health Organization [WHO] standardized classification CE1).
Diagram of the Echinococcus life cycle. Image courtesy of the Centers for Disease Control and Prevention.
Table 1. Cestodes and Their Hosts
Cestode Primary Host Intermediate Host
T solium Humans Pigs, humans, dogs, cats, sheep
T saginata Humans Cattle
Diphyllobothrium Humans Fish
Hymenolepis Humans Hymenolepis nana: None; Hymenolepis diminuta: Rodents
D caninum Humans, dogs, cats Fleas on dogs/cats
Echinococcus Dogs Humans, sheep, cattle, goats, horses, camel
Spirometra Humans  
T multiceps   Hares, rabbits, squirrels, humans (rarely)
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.